PL02.08 Perioperative vs Neoadjuvant Nivolumab for Resectable NSCLC: Patient-Level Data Analysis of CheckMate 77T vs CheckMate 816
Patrick M. Forde, Solange Peters, J. Donington, S. Meadows–Shropshire, P. Tran, S. Lucherini, C. Coronado Erdmann, Hao Sun, Tina Cascone
Topics & Concepts
MedicineNivolumabPerioperativeInternal medicineOncologySurgeryCancerImmunotherapyGastric Cancer Management and OutcomesCancer Immunotherapy and BiomarkersColorectal Cancer Surgical Treatments